T. Rowe Price Associates’s Cyclerion Therapeutics CYCN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-716,295
| Closed | -$4.36M | – | 2676 |
|
|
2020
Q3 | $4.36M | Buy |
716,295
+96,773
| +16% | +$588K | ﹤0.01% | 1419 |
|
|
2020
Q2 | $3.66M | Sell |
619,522
-59,165
| -9% | -$350K | ﹤0.01% | 1420 |
|
|
2020
Q1 | $1.8M | Buy |
+678,687
| New | +$1.8M | ﹤0.01% | 1526 |
|
|
2019
Q4 | – | Sell |
-231,950
| Closed | -$2.81M | – | 2525 |
|
|
2019
Q3 | $2.81M | Buy |
231,950
+80,191
| +53% | +$972K | ﹤0.01% | 1486 |
|
|
2019
Q2 | $1.74M | Buy |
+151,759
| New | +$1.74M | ﹤0.01% | 1630 |
|